⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Shiga University of Medical Science and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Shiga University of Medical Science (SUMS) is a prominent Japanese national university focused on medical education, research, and clinical care. It operates a university hospital and several research centers, including the Molecular Neuroscience Research Center, dedicated to advancing medical science and patient care.
The institution is deeply involved in clinical research, including trials for diagnostic imaging, regenerative medicine, and neurological disease therapeutics. It maintains strong collaborative ties with both academic institutions and private industry partners to translate research into clinical practice.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Academic Medical Research
SIZE & FINANCIALS
Employees:1001-5000
Founded:1974
Ownership:government
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Clinical Research
Modalities:Diagnostic Imaging, Regenerative medicine, Gene therapy
Active Trials:10
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Dai Nippon Printing Co., Ltd. (AI diagnostic research), Konica Minolta (Dynamic chest radiography research)
COMPETITION
Position:Niche Player
LINKS
Website:belle.shiga-med.ac.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shiga University of Medical Science. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.